Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials.
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials. Ann Allergy Asthma Immunol. 2022 Dec; 129(6):758-768.e4.